Lefno 20 Tablet

Product Introduction

Lefno 20 Tablet is a medication primarily composed of Leflunomide, an immunosuppressive agent used in the treatment of rheumatoid arthritis (RA). It belongs to the class of disease-modifying antirheumatic drugs (DMARDs) that work by suppressing the overactive immune system characteristic of RA. Each tablet typically contains 20 mg of Leflunomide, and it is available in oral form.

Uses of Lefno 20 Tablet

Lefno 20 Tablet is prescribed for the following medical conditions:

• Rheumatoid Arthritis (RA): It is indicated for the treatment of active RA to reduce signs and symptoms, inhibit structural damage, and improve physical function. RA is an autoimmune disorder where the body’s immune system attacks its own tissues, particularly the joints, leading to inflammation, pain, and joint damage.

Benefits of Lefno 20 Tablet

• Reduction of Symptoms: Lefno 20 Tablet helps alleviate the symptoms of rheumatoid arthritis such as joint pain, swelling, and stiffness. By suppressing the immune response that causes inflammation, it can improve mobility and overall quality of life for RA patients.
• Inhibition of Disease Progression: By slowing down the progression of joint damage and deformity associated with RA, Lefno 20 Tablet helps preserve joint function and mobility over time.

Side Effects of Lefno 20 Tablet

Like all medications, Lefno 20 Tablet may cause side effects. Common side effects include:

• Gastrointestinal Effects: These may include diarrhea, nausea, vomiting, and abdominal pain. Taking the medication with food can help reduce these symptoms.
• Liver Function Abnormalities: Leflunomide can affect liver enzymes, leading to elevated liver function tests. Regular monitoring of liver function is recommended during treatment.
• Skin Reactions: Some patients may experience skin rash or itching.
• Respiratory Effects: Occasionally, cough or respiratory infections may occur.
• Hematologic Effects: Rarely, Lefno 20 Tablet may cause changes in blood cell counts, which can be detected through blood tests.
• Teratogenicity: Leflunomide is known to cause birth defects if used during pregnancy. Thus, it is contraindicated in pregnant women or those planning pregnancy unless they undergo a washout procedure to eliminate the drug from their system.